Results 291 to 300 of about 467,609 (357)

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Anthracyclines are among the most effective chemotherapeutic agents used to treat pediatric malignancies. However, their clinical use is limited by dose‐dependent toxicities, particularly cardiotoxicity and secondary malignancies.
Darleen S. Tu, Aaron K. Olson, Kimberly S. Waggie, Nicolas M. Garcia, Virginia J. Hoglund, Stephanie I. Walter, Jenna R. Rosinski, Harini Sadeeshkumar, Radhika Patel, Erolcan Sayar, Michael C. Haffner, Lisa Maves, Jacques Neefjes, Jay F. Sarthy, Elizabeth R. Lawlor, Shireen S. Ganapathi   +15 more
wiley   +1 more source

Dual Challenge: Managing Complicated Diphtheria in a Child With Acute Myeloid Leukemia. [PDF]

Cureus
Bhattacharya S, Gaire H, Tulsiyan A, Singh A, Gupta A, Dash S, Nandwani S, Sharma A, Singh DK, Girhotra M, Radhakrishnan N.   +10 more
europepmc   +1 more source

Clonal Evolution of Pediatric Acute Myeloid Leukemia and Its Contribution to Disease Relapse

Umeda M, Kolekar P, Huskey AL, Suryaprakash S, Ma J, Li H, Westover T, Walsh MP, Song G, Liu Y, Tran Q, Balagopal V, Wang L, Brady SW, Gruber TA, Pounds S, Mead PE, Karol SE, Inaba H, Rubnitz JE, Ribeiro R, Ma X, Klco JM.   +22 more
europepmc   +1 more source

Acute Myeloid Leukemia: A Key Role of DGKα and DGKζ in Cell Viability. [PDF]

Cells
Gorla E, Cartella MC, Borghetti E, Lovati G, Racca L, Gravina T, Biazzo G, Bonello G, Malacarne V, De Giorgis V, Corà D, Manfredi M, Massarotti A, Graziani A, Baldanzi G.   +14 more
europepmc   +1 more source

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia. [PDF]

Hemasphere
Leonetti F, Kosanovic S, Rebollidos-Rios R, Manosalva I, Baier C, Yazir M, Constantinescu A, Souaid C, Pequerul R, Adamcova MK, Shaikh M, Havlová M, Costello R, Farrés J, Martin G, Alberich-Jorda M, Spicuglia S, Perez-Alea M.   +17 more
europepmc   +1 more source

FIGURE 2 from Autophagy Inhibition–induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia Cells

Tomohisa Baba, Utano Tomaru, Atsushi Hirao, Naofumi Mukaida, Yoshikazu Johmura   +4 more
openalex   +1 more source

Olverembatinib in chronic myeloid leukemia: is less actually better? [PDF]

Haematologica
Perusini MA, Kim DDH.
europepmc   +1 more source

<i>MECOM</i>-Rearranged Acute Myeloid Leukemia: Pathobiology and Management Strategies. [PDF]

Hematol Rep
Joshi U, Shallis RM.
europepmc   +1 more source

Deep Learning links TP53 genotype to expression-defined transcriptional program in Acute Myeloid Leukemia

Tsesmelis M, Andersson R, Perez AF, Vazquez SM, Carolina Florian M, Mulaw MA.   +5 more
europepmc   +1 more source